Global Metabolomics Biomarker Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 115 pages | ID: GDEADA92691EN
GlobalInfoResearch

Abstracts

Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms.

Scope of the Report:

Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period. Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market.
The global Metabolomics Biomarker market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabolomics Biomarker.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Metabolomics Biomarker market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metabolomics Biomarker market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Biocrates Life Sciences
• Biomark Diagnostics
• Chenomx
• Creative Proteomics
• Evotec
• Human Metabolome Technologies
• Merck
• Metabolomic Diagnostics
• Metabolon
• Ovid Therapeutics

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Gas chromatography
• High-performance liquid chromatography
• Ultra-performance liquid chromatography
• Nuclear magnetic resonance
• Mass spectrometry
• Surface-based mass analysis
• Bioinformatics

Market Segment by Applications, can be divided into

• Toxicological studies
• Drug testing
• Cancer
• Cardiovascular disorders
• Neurological disorders
• Inborn errors of metabolism

Contents

1 METABOLOMICS BIOMARKER MARKET OVERVIEW

1.1 Product Overview and Scope of Metabolomics Biomarker
1.2 Classification of Metabolomics Biomarker by Types
  1.2.1 Global Metabolomics Biomarker Revenue Comparison by Types (2017-2023)
  1.2.2 Global Metabolomics Biomarker Revenue Market Share by Types in 2017
  1.2.3 Gas chromatography
  1.2.4 High-performance liquid chromatography
  1.2.5 Ultra-performance liquid chromatography
  1.2.6 Nuclear magnetic resonance
  1.2.7 Mass spectrometry
  1.2.8 Surface-based mass analysis
  1.2.9 Bioinformatics
1.3 Global Metabolomics Biomarker Market by Application
  1.3.1 Global Metabolomics Biomarker Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Toxicological studies
  1.3.3 Drug testing
  1.3.4 Cancer
  1.3.5 Cardiovascular disorders
  1.3.6 Neurological disorders
  1.3.7 Inborn errors of metabolism
1.4 Global Metabolomics Biomarker Market by Regions
  1.4.1 Global Metabolomics Biomarker Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Metabolomics Biomarker Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolomics Biomarker Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolomics Biomarker Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Metabolomics Biomarker Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolomics Biomarker Status and Prospect (2013-2023)
1.5 Global Market Size of Metabolomics Biomarker (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Biocrates Life Sciences
  2.1.1 Business Overview
  2.1.2 Metabolomics Biomarker Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.2 Biomark Diagnostics
  2.2.1 Business Overview
  2.2.2 Metabolomics Biomarker Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.3 Chenomx
  2.3.1 Business Overview
  2.3.2 Metabolomics Biomarker Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.4 Creative Proteomics
  2.4.1 Business Overview
  2.4.2 Metabolomics Biomarker Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.5 Evotec
  2.5.1 Business Overview
  2.5.2 Metabolomics Biomarker Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.6 Human Metabolome Technologies
  2.6.1 Business Overview
  2.6.2 Metabolomics Biomarker Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
  2.7.1 Business Overview
  2.7.2 Metabolomics Biomarker Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.8 Metabolomic Diagnostics
  2.8.1 Business Overview
  2.8.2 Metabolomics Biomarker Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.9 Metabolon
  2.9.1 Business Overview
  2.9.2 Metabolomics Biomarker Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ovid Therapeutics
  2.10.1 Business Overview
  2.10.2 Metabolomics Biomarker Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL METABOLOMICS BIOMARKER MARKET COMPETITION, BY PLAYERS

3.1 Global Metabolomics Biomarker Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Metabolomics Biomarker Players Market Share
  3.2.2 Top 10 Metabolomics Biomarker Players Market Share
3.3 Market Competition Trend

4 GLOBAL METABOLOMICS BIOMARKER MARKET SIZE BY REGIONS

4.1 Global Metabolomics Biomarker Revenue and Market Share by Regions
4.2 North America Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
4.3 Europe Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
4.5 South America Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA METABOLOMICS BIOMARKER REVENUE BY COUNTRIES

5.1 North America Metabolomics Biomarker Revenue by Countries (2013-2018)
5.2 USA Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
5.3 Canada Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
5.4 Mexico Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

6 EUROPE METABOLOMICS BIOMARKER REVENUE BY COUNTRIES

6.1 Europe Metabolomics Biomarker Revenue by Countries (2013-2018)
6.2 Germany Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
6.3 UK Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
6.4 France Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
6.5 Russia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
6.6 Italy Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC METABOLOMICS BIOMARKER REVENUE BY COUNTRIES

7.1 Asia-Pacific Metabolomics Biomarker Revenue by Countries (2013-2018)
7.2 China Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
7.3 Japan Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
7.4 Korea Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
7.5 India Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA METABOLOMICS BIOMARKER REVENUE BY COUNTRIES

8.1 South America Metabolomics Biomarker Revenue by Countries (2013-2018)
8.2 Brazil Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
8.3 Argentina Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
8.4 Colombia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE METABOLOMICS BIOMARKER BY COUNTRIES

9.1 Middle East and Africa Metabolomics Biomarker Revenue by Countries (2013-2018)
9.2 Saudi Arabia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
9.3 UAE Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
9.4 Egypt Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
9.5 Nigeria Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
9.6 South Africa Metabolomics Biomarker Revenue and Growth Rate (2013-2018)

10 GLOBAL METABOLOMICS BIOMARKER MARKET SEGMENT BY TYPE

10.1 Global Metabolomics Biomarker Revenue and Market Share by Type (2013-2018)
10.2 Global Metabolomics Biomarker Market Forecast by Type (2018-2023)
10.3 Gas chromatography Revenue Growth Rate (2013-2023)
10.4 High-performance liquid chromatography Revenue Growth Rate (2013-2023)
10.5 Ultra-performance liquid chromatography Revenue Growth Rate (2013-2023)
10.6 Nuclear magnetic resonance Revenue Growth Rate (2013-2023)
10.7 Mass spectrometry Revenue Growth Rate (2013-2023)
10.8 Surface-based mass analysis Revenue Growth Rate (2013-2023)
10.9 Bioinformatics Revenue Growth Rate (2013-2023)

11 GLOBAL METABOLOMICS BIOMARKER MARKET SEGMENT BY APPLICATION

11.1 Global Metabolomics Biomarker Revenue Market Share by Application (2013-2018)
11.2 Metabolomics Biomarker Market Forecast by Application (2018-2023)
11.3 Toxicological studies Revenue Growth (2013-2018)
11.4 Drug testing Revenue Growth (2013-2018)
11.5 Cancer Revenue Growth (2013-2018)
11.6 Cardiovascular disorders Revenue Growth (2013-2018)
11.7 Neurological disorders Revenue Growth (2013-2018)
11.8 Inborn errors of metabolism Revenue Growth (2013-2018)

12 GLOBAL METABOLOMICS BIOMARKER MARKET SIZE FORECAST (2018-2023)

12.1 Global Metabolomics Biomarker Market Size Forecast (2018-2023)
12.2 Global Metabolomics Biomarker Market Forecast by Regions (2018-2023)
12.3 North America Metabolomics Biomarker Revenue Market Forecast (2018-2023)
12.4 Europe Metabolomics Biomarker Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Metabolomics Biomarker Revenue Market Forecast (2018-2023)
12.6 South America Metabolomics Biomarker Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Metabolomics Biomarker Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Metabolomics Biomarker Picture
Table Product Specifications of Metabolomics Biomarker
Table Global Metabolomics Biomarker and Revenue (Million USD) Market Split by Product Type
Figure Global Metabolomics Biomarker Revenue Market Share by Types in 2017
Figure Gas chromatography Picture
Figure High-performance liquid chromatography Picture
Figure Ultra-performance liquid chromatography Picture
Figure Nuclear magnetic resonance Picture
Figure Mass spectrometry Picture
Figure Surface-based mass analysis Picture
Figure Bioinformatics Picture
Table Global Metabolomics Biomarker Revenue (Million USD) by Application (2013-2023)
Figure Metabolomics Biomarker Revenue Market Share by Applications in 2017
Figure Toxicological studies Picture
Figure Drug testing Picture
Figure Cancer Picture
Figure Cardiovascular disorders Picture
Figure Neurological disorders Picture
Figure Inborn errors of metabolism Picture
Table Global Market Metabolomics Biomarker Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Metabolomics Biomarker Revenue (Million USD) and Growth Rate (2013-2023)
Table Biocrates Life Sciences Basic Information, Manufacturing Base and Competitors
Table Biocrates Life Sciences Metabolomics Biomarker Type and Applications
Table Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Biomark Diagnostics Basic Information, Manufacturing Base and Competitors
Table Biomark Diagnostics Metabolomics Biomarker Type and Applications
Table Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Chenomx Basic Information, Manufacturing Base and Competitors
Table Chenomx Metabolomics Biomarker Type and Applications
Table Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table Creative Proteomics Metabolomics Biomarker Type and Applications
Table Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Evotec Basic Information, Manufacturing Base and Competitors
Table Evotec Metabolomics Biomarker Type and Applications
Table Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Human Metabolome Technologies Basic Information, Manufacturing Base and Competitors
Table Human Metabolome Technologies Metabolomics Biomarker Type and Applications
Table Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Metabolomics Biomarker Type and Applications
Table Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Metabolomic Diagnostics Basic Information, Manufacturing Base and Competitors
Table Metabolomic Diagnostics Metabolomics Biomarker Type and Applications
Table Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Metabolon Basic Information, Manufacturing Base and Competitors
Table Metabolon Metabolomics Biomarker Type and Applications
Table Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Ovid Therapeutics Basic Information, Manufacturing Base and Competitors
Table Ovid Therapeutics Metabolomics Biomarker Type and Applications
Table Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2017)
Table Global Metabolomics Biomarker Revenue (Million USD) by Players (2013-2018)
Table Global Metabolomics Biomarker Revenue Share by Players (2013-2018)
Figure Global Metabolomics Biomarker Revenue Share by Players in 2016
Figure Global Metabolomics Biomarker Revenue Share by Players in 2017
Figure Global Top 5 Players Metabolomics Biomarker Revenue Market Share in 2017
Figure Global Top 10 Players Metabolomics Biomarker Revenue Market Share in 2017
Figure Global Metabolomics Biomarker Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Metabolomics Biomarker Revenue (Million USD) by Regions (2013-2018)
Table Global Metabolomics Biomarker Revenue Market Share by Regions (2013-2018)
Figure Global Metabolomics Biomarker Revenue Market Share by Regions (2013-2018)
Figure Global Metabolomics Biomarker Revenue Market Share by Regions in 2017
Figure North America Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Europe Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure South America Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Table North America Metabolomics Biomarker Revenue by Countries (2013-2018)
Table North America Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure North America Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure North America Metabolomics Biomarker Revenue Market Share by Countries in 2017
Figure USA Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Canada Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Mexico Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Table Europe Metabolomics Biomarker Revenue (Million USD) by Countries (2013-2018)
Figure Europe Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure Europe Metabolomics Biomarker Revenue Market Share by Countries in 2017
Figure Germany Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure UK Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure France Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Russia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Italy Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Metabolomics Biomarker Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Metabolomics Biomarker Revenue Market Share by Countries in 2017
Figure China Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Japan Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Korea Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure India Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Table South America Metabolomics Biomarker Revenue by Countries (2013-2018)
Table South America Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure South America Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure South America Metabolomics Biomarker Revenue Market Share by Countries in 2017
Figure Brazil Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Argentina Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Colombia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Metabolomics Biomarker Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Metabolomics Biomarker Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Metabolomics Biomarker Revenue Market Share by Countries in 2017
Figure Saudi Arabia Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure UAE Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Egypt Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure Nigeria Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Figure South Africa Metabolomics Biomarker Revenue and Growth Rate (2013-2018)
Table Global Metabolomics Biomarker Revenue (Million USD) by Type (2013-2018)
Table Global Metabolomics Biomarker Revenue Share by Type (2013-2018)
Figure Global Metabolomics Biomarker Revenue Share by Type (2013-2018)
Figure Global Metabolomics Biomarker Revenue Share by Type in 2017
Table Global Metabolomics Biomarker Revenue Forecast by Type (2018-2023)
Figure Global Metabolomics Biomarker Market Share Forecast by Type (2018-2023)
Figure Global Gas chromatography Revenue Growth Rate (2013-2018)
Figure Global High-performance liquid chromatography Revenue Growth Rate (2013-2018)
Figure Global Ultra-performance liquid chromatography Revenue Growth Rate (2013-2018)
Figure Global Nuclear magnetic resonance Revenue Growth Rate (2013-2018)
Figure Global Mass spectrometry Revenue Growth Rate (2013-2018)
Figure Global Surface-based mass analysis Revenue Growth Rate (2013-2018)
Figure Global Bioinformatics Revenue Growth Rate (2013-2018)
Table Global Metabolomics Biomarker Revenue by Application (2013-2018)
Table Global Metabolomics Biomarker Revenue Share by Application (2013-2018)
Figure Global Metabolomics Biomarker Revenue Share by Application (2013-2018)
Figure Global Metabolomics Biomarker Revenue Share by Application in 2017
Table Global Metabolomics Biomarker Revenue Forecast by Application (2018-2023)
Figure Global Metabolomics Biomarker Market Share Forecast by Application (2018-2023)
Figure Global Toxicological studies Revenue Growth Rate (2013-2018)
Figure Global Drug testing Revenue Growth Rate (2013-2018)
Figure Global Cancer Revenue Growth Rate (2013-2018)
Figure Global Cardiovascular disorders Revenue Growth Rate (2013-2018)
Figure Global Neurological disorders Revenue Growth Rate (2013-2018)
Figure Global Inborn errors of metabolism Revenue Growth Rate (2013-2018)
Figure Global Metabolomics Biomarker Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Metabolomics Biomarker Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Metabolomics Biomarker Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Metabolomics Biomarker Revenue Market Forecast (2018-2023)
Figure Europe Metabolomics Biomarker Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Metabolomics Biomarker Revenue Market Forecast (2018-2023)
Figure South America Metabolomics Biomarker Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Metabolomics Biomarker Revenue Market Forecast (2018-2023)